NAD+ 500mg — Verification Report
From TriVial BioWorks · Lot ND500-0508 · Tested May 2026
VialTalk
NAD+ 500mg
TriVial BioWorks
Score
103.8
Grade
A++
Superlative
Lot ND500-0508
Tested May 2026
Report ID
ed9d86e8
Test
Method
Result
Status
PurityFull credit
HPLC
99.49%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim
500 mg labeled · 519.47 mg tested
Full credit
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Heavy metalsFull credit
ICP-MS
Screened
Full credit
Batch conformityPartial
Two-batch average
Assessed
Partial
SterilityNot submitted
Not tested
Not tested
Not submitted
Additional screens, not scoredFentanyl screen
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/trivial-bioworks/coas/ed9d86e8-12b1-4e67-8f3f-a955b553668a